Can we target cancer’s metabolism by combining new drugs with a fat-free diet? 19 Jun 2020 The ICR’s Dr George Poulogiannis and his team have revealed a metabolic weakness in cancer that could be targeted by combining new drugs with a diet free of omega-6 fats. Our Media Officer Diana Cano Bordajandi explains the research findings and their potential implications. Find out more Show/Hide
Men’s Health Week: How our researchers are transforming prostate cancer treatment 15 Jun 2020 Professor Nick James, Chief Investigator of the STAMPEDE trial, joined the ICR in December 2019 and is one of our newest Team Leaders. Diana Cano Bordajandi met him to find out more about his current research and future plans, which will help us answer key questions on how to treat men with prostate cancer. Find out more Show/Hide
ASCO 2020: Cancer researchers get together at a distance 29 May 2020 At a time when cancer researchers usually descend on Chicago for the biggest cancer conference of the year, Sarah Wells looks ahead at some of the highlights that researchers from The Institute of Cancer Research will be presenting at this year’s virtual edition of the ASCO Annual Meeting. Find out more Show/Hide
Prostate Cancer Awareness Month 2020: Immunotherapy, state-of-the-art radiotherapy, olaparib and PSA screening 24 Mar 2020
Weighing in on breast cancer risk – considering the effect of weight gain before the menopause 13 Mar 2020